8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
An expert overview of the literature, useful as background reading.
2020 / Narrative review
This narrative review summarizes current evidence regarding the neuroendocrine and metabolic effects of low- and non-calorie sweeteners, including their impact on the central nervous system, gut hormones, and gut microbiota. While sweeteners may help reduce calorie intake and prevent weight gain, studies examining their short- and long-term safety and efficacy are scarce and controversial. The authors note the need for future studies to elucidate beneficial and detrimental effects across healthy populations and those with metabolic disorders, and discuss sweetener use in very-low calorie ketogenic diets.
Moriconi E, Feraco A, Marzolla V, et al. Front Endocrinol (Lausanne), 2020. PMID 32765425
2020 / Literature review
A literature review evaluated recent meta-analyses of longitudinal observational studies and clinical trials assessing vitamin D and incident diabetes. Longitudinal observational studies reported consistent associations between higher blood 25(OH)D levels and lower incident diabetes risk across diverse populations. In three large trials designed for diabetes prevention, vitamin D supplementation lowered diabetes risk by 10% to 13% compared with placebo in people with prediabetes who were not selected for vitamin D deficiency.
Pittas AG, Jorde R, Kawahara T, et al. J Clin Endocrinol Metab, 2020. PMID 32844212
2019 / Narrative review
This review summarizes evidence on plant sterol and stanol (PS) fortified foods for managing hypercholesterolemia. Meta-analyses of over 100 controlled clinical trials demonstrate that 2-3 g per day of PS yields a 9-12% reduction in LDL-cholesterol. In patients taking statins, the average LDL reduction with PS equals up-titrating the statin dose twice. A key limitation noted is the current lack of clinical trials evaluating the effects of PS on cardiovascular events.
Cofán M, Ros E Curr Med Chem, 2019. PMID 29984649
2019 / Narrative review
Following a James Lind Alliance survey identifying diabetes reversal as the top research priority among people with type 2 diabetes, this review summarizes current evidence on weight loss-induced remission. Current data indicate long-term stable β-cell function occurs if weight regain is prevented, whereas returning to previous weight leads to recurrence. The review also notes that the chance of achieving reversal steadily diminishes with increasing duration of type 2 diabetes.
Taylor R, Barnes AC Diabet Med, 2019. PMID 30378706
2019 / Clinical review of clinical trials
This review examined clinical trials on Berberis vulgaris and its alkaloid constituent berberine across electronic databases. Across 77 human clinical studies, lipid-lowering and insulin-resistance improving actions were the most frequently studied properties, alongside cardiovascular, anticancer, gastrointestinal, CNS, and endocrine applications. Berberine demonstrated very low toxicity at usual doses with no major side effects, though mild gastrointestinal reactions occurred in some patients.
Imenshahidi M, Hosseinzadeh H Phytother Res, 2019. PMID 30637820
2019 / Narrative review
This review discusses a series of studies showing that accumulation of fat in the liver and pancreas leads to beta cell dedifferentiation and type 2 diabetes. Normal blood glucose can be restored by removing excess fat from these organs through substantial weight loss. The resulting post-diabetes state can be long-term provided weight regain is avoided.
Taylor R Clin Med (Lond), 2019. PMID 30651243
2019 / Narrative review of clinical trials
This review evaluates clinical evidence on the polyphenolic nutraceutical resveratrol, whose efficacy, safety, and pharmacokinetics have been documented in over 244 clinical trials with 27 ongoing. Resveratrol is reported to potentially improve therapeutic outcomes in conditions such as diabetes mellitus, obesity, cancers, metabolic syndrome, hypertension, Alzheimer's disease, cardiovascular diseases, and kidney diseases. It is reported to be safe at doses up to 5 g/day alone or in combination therapy. However, its therapeutic use is limited by rapid metabolism and poor bioavailability, though a micronized formulation (SRT501) shows promise.
Singh AP, Singh R, Verma SS, et al. Med Res Rev, 2019. PMID 30741437
2019 / Narrative review
This review discusses clinical and pathophysiological studies showing that type 2 diabetes is largely driven by reversible fat accumulation in the liver and pancreas. Removal of this excess fat through substantial weight loss can normalize hepatic insulin responsiveness and allow recovery of acute insulin secretion by beta cells, normalizing blood glucose. In the primary care-based DiRECT trial, weight loss mediated type 2 diabetes remission in 46% of individuals at 12 months and 36% at 24 months.
Taylor R, Al-Mrabeh A, Sattar N Lancet Diabetes Endocrinol, 2019. PMID 31097391
2019 / Case report and literature review
A 54-year-old female presenting with grade 3 obesity (BMI 45.2 kg/m2), type II diabetes (A1c 8.1%), and heart failure with depressed left ventricular systolic function transitioned to a whole food plant-based diet alongside guideline-directed medical therapy. Over five and a half months, she lost 22.7 kg, reversed her diabetes without diabetes medications, and normalized her left ventricular systolic function. The authors noted that causality cannot be determined from this case report.
Allen KE, Gumber D, Ostfeld RJ Front Nutr, 2019. PMID 31245377
2019 / Narrative review
A review of epidemiologic and biochemical evidence evaluated trans fatty acid (TFA) intake and chronic disease risks. A 2% absolute increase in energy intake from trans fat has been associated with a 23% increase in cardiovascular risk. TFAs increase low-density lipoprotein levels, and several epidemiological studies demonstrate that high TFA intake increases the incidence of cancer and diabetes. Complete elimination of TFAs is not possible in a balanced diet due to their natural presence in dairy and meat products.
Shows an association, not proof of cause and effect.
Islam MA, Amin MN, Siddiqui SA, et al. Diabetes Metab Syndr, 2019. PMID 31336535
2019 / Narrative review
This review examines the role of the short-chain fatty acid acetate in body weight control and glucose homeostasis. Animal and human data show that acetate beneficially affects host energy and substrate metabolism via secretion of glucagon-like peptide-1 and peptide YY, reducing whole-body lipolysis and systemic pro-inflammatory cytokines, and increasing energy expenditure and fat oxidation. It details approaches including oral acetate (vinegar intake), colonic infusions, acetogenic fiber, and acetogenic probiotics. The authors emphasize that human data are scarce, highlighting the need for further human research.
Hernández MAG, Canfora EE, Jocken JWE, et al. Nutrients, 2019. PMID 31426593
2019 / Narrative review
This review evaluates the effect of diet composition on insulin sensitivity and disease risk. Prospective studies indicate that diets high in animal products and low in plant foods increase the risk of type 2 diabetes and cardiovascular disease. In healthy individuals and patients with diabetes, animal protein intake worsens insulin resistance independently of BMI, whereas plant foods enhance insulin sensitivity. Additionally, pre-pregnancy meat intake is strongly linked to higher gestational diabetes risk, while pre-pregnancy vegetable protein is associated with lower risk. Diets restricting carbohydrates while increasing animal protein worsen insulin resistance even after weight loss.
Adeva-Andany MM, González-Lucán M, Fernández-Fernández C, et al. Clin Nutr ESPEN, 2019. PMID 31451269
2019 / Perspective / narrative review
This commentary discusses the unsustainable rise in US health care costs since the 1980s, noting that over 70% of health care dollars address the consequences of unhealthy lifestyles tied to obesity, diabetes, and cardiovascular disease. The author also notes an epidemic of physician burnout in the US. Based on these challenges, the author presents the perspective that a whole-foods, plant-based diet may support health, health care sustainability, and physician wellness.
Ha B Perm J, 2019. PMID 31496505
2019 / Perspective / narrative commentary
Obesity is a major risk factor for type 2 diabetes and cardiovascular disease, conditions that can be prevented and treated with nutritional interventions involving plant-based diets. Although many patients look to doctors for dietary advice, most physicians lack adequate nutrition education to provide meaningful guidance. Educational programs launched for physicians and patients regarding the benefits of plant-based diets received an overwhelmingly positive response.
Rahman V Perm J, 2019. PMID 31496507
2019 / Narrative review
This review investigated the role of adapted, short-term, hypocaloric, low-fat, and plant-based dietary oatmeal interventions for patients with poorly-controlled type 2 diabetes. Searching PubMed and Google Scholar, the authors found a limited number of clinical studies evaluating these interventions. Available evidence indicated that short-term dietary oatmeal interventions may lead to significant decreases in mean blood glucose levels and significant reductions in required insulin doses.
Storz MA, Küster O Nutr Health, 2019. PMID 31500515
2019 / Narrative review
This review evaluated the current prevalence, health benefits, and health risks associated with vegetarian diets. Compared to the Adventist Health Study 2, more recent prospective studies have demonstrated significant although smaller risk reductions for mortality in cardiovascular disease, cerebrovascular disease, diabetes mellitus, and chronic kidney disease. The review also notes potential health risks including deficiencies in protein, omega-3 fatty acids, vitamin D, vitamin B12, iron, calcium, and zinc.
Shows an association, not proof of cause and effect.
Rocha JP, Laster J, Parag B, et al. Curr Nutr Rep, 2019. PMID 31705483
2019 / Narrative review
This review discusses the intertwined burdens of diet-related chronic diseases and environmental degradation caused by current global dietary patterns and food systems. Shifting toward healthy plant-based diets, compared with typical Western diets high in animal products, has been associated with lower risks of obesity, type 2 diabetes, cardiovascular disease, and some cancers, while also improving sustainability. While precision nutrition may offer tailored disease prevention, it is in its early stages and not ready for widespread clinical use, underscoring the ongoing importance of broader public health nutrition strategies.
Shows an association, not proof of cause and effect.
Hemler EC, Hu FB Adv Nutr, 2019. PMID 31728495
2019 / Narrative review of animal and human studies
This review evaluated the effects of Moringa oleifera (MO) on glycaemia and insulin levels across animal and human studies. Acute antihyperglycemic effects of MO extract appear robust in diabetic animal models, though chronic studies are still needed. Conversely, hypoglycemic effects in humans are not as clear, potentially due to a scarce number of studies, diverse methodologies, and variable doses. Evidence concerning changes in insulin levels remains ambiguous in both animal and human studies.
Vargas-Sánchez K, Garay-Jaramillo E, González-Reyes RE Nutrients, 2019. PMID 31810205
2019 / Narrative review
This review evaluated the evidence on plant-based diets and health outcomes, examining how these benefits translate to Black individuals in the United States. Although substantial evidence supports plant-based diets in the general population, little research has focused specifically on Black populations. Available data suggest that plant-based diets may reduce the risk of heart disease and possibly cancer in this group. The authors note that more research is needed on cardiovascular risk factors, cancer subtypes, and other chronic diseases, emphasizing the need for culturally appropriate interventions.
Shows an association, not proof of cause and effect.
Sterling SR, Bowen SA Nutrients, 2019. PMID 31810250
2019 / Updated systematic review of meta-analyses
An updated electronic search of PubMed/MEDLINE, CINAHL, and Cochrane Library identified seven new meta-analyses examining nut consumption and cardiometabolic diseases. Comparing high with low consumption categories, nut intake significantly decreased CVD mortality (-19% to -25%; n = 4), CHD mortality (-24% to -30%; n = 3), stroke mortality (-17% to -18%; n = 3), CVD incidence (-15% to -19%; n = 4), CHD/CAD incidence (-17% to -34%; n = 8), and stroke incidence (-10% to -11%; n = 6). Compared with control diets, nut consumption significantly reduced fasting glucose (0.08 to 0.15 mmol/L; n = 6), total cholesterol (0.021 to 0.30 mmol/L; n = 10), and LDL-C (0.017 to 0.26 mmol/L; n = 10). Body weight and blood pressure were not significantly affected.
Shows an association, not proof of cause and effect.
Kim Y, Keogh JB, Clifton PM Int J Environ Res Public Health, 2019. PMID 31817639
2019 / Narrative review
Atrial fibrillation affects an estimated 34 million individuals globally and carries a significant burden of morbidity and mortality. This review examines evidence regarding the use of a whole-food plant-based diet—emphasizing grains, legumes, vegetables, fruits, and nuts while excluding most or all animal products—for managing atrial fibrillation risk factors. It highlights effects on cardiovascular and metabolic factors including hypertension, coronary artery disease, diabetes, obesity, inflammation, and subclinical atherosclerosis.
Storz MA, Helle P J Arrhythm, 2019. PMID 31844466
2019 / Narrative review
This review describes the formation of advanced glycation end products (AGEs) during high-temperature cooking and their pathophysiological associations. Glycated Maillard products are linked to type 2 diabetes, acute renal failure, Alzheimer's disease, dental health, allergies, and polycystic ovary syndrome (PCOS). In diabetes, high levels of AGEs correlate with carotid thickening, ischemic heart disease, uremic cardiomyopathy, and kidney failure. Furthermore, infant formula milk is identified as a rich source of primary adducts like carboxy-methyl lysine, potentially rendering infants prone to inflammation, dementia, and food allergies.
Shows an association, not proof of cause and effect.
Gill V, Kumar V, Singh K, et al. Biomolecules, 2019. PMID 31861217
2018 / Case-based review
This article discusses two clinical cases and reviews practical approaches to managing obesity and type 2 diabetes, focusing on non-surgical metabolic rehabilitation. The authors note that referral to a multidisciplinary outpatient program may be necessary for more complicated patients, and it is not uncommon for patients to lose between 10-20% of their initial weight. Despite this, metabolic surgery may be required for further weight loss and long-term maintenance. Based on clinical experience, the authors suggest intensive, multidisciplinary rehabilitation with supervised exercise as the gold standard of care.
Bishay RH, Kormas N Curr Diabetes Rev, 2018. PMID 28359235
2018 / Narrative review / commentary
This article discusses the role of lifestyle choices in health and chronic disease prevention. It notes that approximately 80% of chronic disease and premature death could be prevented by avoiding smoking, engaging in physical activity, and following a healthful dietary pattern. Cardiovascular disease, diabetes, stroke, dementia, and cancer are all influenced by lifestyle. The author argues for a global coalition of experts to clarify confusing nutrition messages and promote health-promoting diet and lifestyle patterns.
Katz DL, Frates EP, Bonnet JP, et al. Am J Health Promot, 2018. PMID 28523941